---
title: "Modelling for Public Health Policy"
subtitle: "Using mathematical models to inform health policy decisions"
page-layout: article
title-block-banner: "#2c3e50"
title-block-banner-color: white
---

```{=html}
<style>
.highlight-card {
  border-left: 4px solid #56cc9d;
  background: linear-gradient(135deg, #f8f9fa 0%, #e5f9f0 100%);
  padding: 1.5rem;
  margin: 1.5rem 0;
  border-radius: 0 8px 8px 0;
}

.project-card {
  background: white;
  border: 1px solid #dee2e6;
  border-radius: 12px;
  padding: 1.5rem;
  margin: 1rem 0;
  box-shadow: 0 2px 8px rgba(0,0,0,0.08);
  transition: transform 0.2s ease, box-shadow 0.2s ease;
}

.project-card:hover {
  transform: translateY(-2px);
  box-shadow: 0 4px 16px rgba(0,0,0,0.12);
}

.project-card h3 {
  color: #2c3e50;
  margin-bottom: 0.75rem;
  font-size: 1.25rem;
}

.pub-item {
  background: #f8f9fa;
  padding: 1rem 1.25rem;
  margin: 0.75rem 0;
  border-radius: 8px;
  border-left: 3px solid #56cc9d;
}

.pub-item:hover {
  background: #e9ecef;
}

.section-header {
  border-bottom: 2px solid #56cc9d;
  padding-bottom: 0.5rem;
  margin-top: 2.5rem;
  margin-bottom: 1.5rem;
}

.featured-image {
  border-radius: 12px;
  box-shadow: 0 4px 20px rgba(0,0,0,0.15);
  margin: 2rem 0;
}

.back-link {
  display: inline-flex;
  align-items: center;
  gap: 0.5rem;
  color: #6c757d;
  text-decoration: none;
  font-weight: 500;
  margin-top: 2rem;
  padding: 0.5rem 1rem;
  border-radius: 6px;
  transition: all 0.2s ease;
}

.back-link:hover {
  background: #f8f9fa;
  color: #2c3e50;
}

.key-points {
  display: grid;
  grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
  gap: 1rem;
  margin: 1.5rem 0;
}

.key-point {
  background: #e5f9f0;
  padding: 1rem;
  border-radius: 8px;
  text-align: center;
  font-weight: 500;
  color: #2c3e50;
}
</style>
```

::: {.highlight-card}
**Focus:** Developing and applying mathematical models to evaluate intervention strategies and support evidence-based public health decision-making.
:::

![](../images/placeholder_policy.jpg){.featured-image fig-align="center" width="100%"}

## Scenario Modelling {.section-header}

::: {.project-card}
### COVID-19 Vaccination Strategies in the Netherlands

Scenario modelling at RIVM (the Dutch National Institute for Public Health and the Environment) to anticipate the impact of COVID-19 vaccination strategies on disease outcomes in the Netherlands. A deterministic age-structured compartmental model (**vacamole**) was used to compare scenarios with respect to infections, hospitalisations, ICU admissions, and deaths — including analyses of vaccination in adolescents and children, rollout strategies, and booster campaign timing.

::: {.pub-item}
**Ainslie, K. E. C.**, *et al*. A scenario modelling analysis to anticipate the impact of COVID-19 vaccination in adolescents and children on disease outcomes in the Netherlands, summer 2021. *Euro Surveill.* 2022. [Read paper →](https://doi.org/10.2807/1560-7917.ES.2022.27.44.2101090)
:::

::: {.pub-item}
**Ainslie, K. E. C.** *et al.* The expected outcome of COVID-19 vaccination strategies. RIVM 2021. [Read report →](https://www.rivm.nl/documenten/expected-outcome-of-covid-19-vaccination-strategies)
:::

::: {.pub-item}
Miura, F., Leung, K. Y., Klinkenberg, D., **Ainslie, K. E. C.**, Wallinga, J. Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritisation analysis. *PLOS Computational Biology* 2021. [Read paper →](https://doi.org/10.1371/journal.pcbi.1009697)
:::

**Related software:** [vacamole](https://github.com/kylieainslie/vacamole){.btn .btn-success .btn-sm}
:::

::: {.project-card}
### European Scenario Modelling Hub

The [**European COVID-19 Scenario Modelling Hub**](https://covid19scenariohub.eu/) brought together modelling teams across Europe to produce ensemble projections for policy planning. Multi-model approaches were used to capture uncertainty in epidemic projections and inform public health planning across multiple countries.

::: {.pub-item}
Sherratt, K., *et al*. Characterising information gains and losses when collecting multiple epidemic model outputs. *Epidemics* 2024. [Read paper →](https://doi.org/10.1016/j.epidem.2024.100765)
:::

**Related software:** [European Scenario Hub](https://github.com/european-modelling-hubs/covid19-scenario-hub-europe){.btn .btn-outline-secondary .btn-sm}
:::

## Non-Pharmaceutical Interventions {.section-header}

::: {.project-card}
### NPI Evaluation During COVID-19

Quantifying the impact of non-pharmaceutical interventions — lockdowns, school closures, and bans on public gatherings — was critical for informing government decisions on intervention timing and stringency. This work estimated NPI effectiveness across European countries during the first wave and examined exit strategies from strict social distancing measures.

::: {.pub-item}
Flaxman, S., Mishra, S., Gandy, A., *et al*. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. *Nature* 2020. [Read paper →](https://doi.org/10.1038/s41586-020-2405-7)
:::

::: {.pub-item}
Dighe, A., Cattarino, L., Cuomo-Dannenburg, G., *et al*. Response to COVID-19 in South Korea and implications for lifting stringent interventions. *BMC Medicine* 2020. [Read paper →](https://doi.org/10.1186/s12916-020-01791-8)
:::
:::

<a href="../research.html" class="back-link">← Back to Research</a>
